• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

LC-MB12

CAS No. 2828438-38-4

LC-MB12 ( —— )

产品货号. M37588 CAS No. 2828438-38-4

LC-MB12 是一种具有口服活性靶向降解 FGFR2 的 PROTAC 化合物,DC50 为 11.8 nM。LC-MB12 包含 BGJ398 (FGFR2 抑制剂), PROTAC linker 和 CRBN。LC-MB12 抑制胃癌细胞 FGFR2 信号,具有抗肿瘤活性。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥2028 有现货
5MG ¥2786 有现货
10MG ¥4441 有现货
25MG ¥8602 有现货
50MG ¥13763 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    LC-MB12
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    LC-MB12 是一种具有口服活性靶向降解 FGFR2 的 PROTAC 化合物,DC50 为 11.8 nM。LC-MB12 包含 BGJ398 (FGFR2 抑制剂), PROTAC linker 和 CRBN。LC-MB12 抑制胃癌细胞 FGFR2 信号,具有抗肿瘤活性。
  • 产品描述
    LC-MB12 is an orally active PROTAC compound targets FGFR2degradation with a DC50 of 11.8 nM. LC-MB12 contains BGJ398 (a FGFR2 inhibitor), PROTAC linker and CRBN.LC-MB12 inhibits FGFR2 signaling in gastric cancer cells and has anti-tumor activity.
  • 体外实验
    Cell Viability Assay Cell Line:KATO III, SNU-16, NCI-H716 Concentration:0.5 nM, 1.5 nM, 4.3 nM, 13 nM, 41 nM, 123 nM, 370 nM, 1111 nM, 3333 nM, 10000 nM Incubation Time:72 h Result:Inhibited cell growth with IC50s value of 29.1 nM (KATO III); 3.7 nM (SNU-16); 3.2 nM (NCI-H716).Cell Cycle Analysis Cell Line:KATO III Concentration:29.1 nM Incubation Time:72 h Result:Induced G0/G1 cycle arrest.ImmunofluorescenceCell Line:KATO IIIConcentration:100 nM Incubation Time:3 h, 6 h Result:Promoted FGFR2 was relocated from the cell membrane to intracellular vesicles after treated for 3 or 6 h. Induced receptor internalization and re-localization to the perinuclear section after 6 h treatment.Western Blot Analysis Cell Line:KATO III, NCI-H1581 Concentration: 0.5 nM, 1.5 nM, 4.3 nM, 13 nM, 41 nM, 123 nM, 370 nM, 1111 nM, 3333 nM, 10000 nM Incubation Time:6 h Result:Degraded FGFR2 with a DC50 of 11.8 nM and D max of ~80% after 6 h of treatment.Showed time-dependent effect on degradation,with a detectable reduction in FGFR2 levels after 3 h of treatment and ~90% degradation after 12 h.Degraded of FGFR2 in KATO by 77%, and in NCI-H1581 by 43% after 100 nM treatment for 6 h.
  • 体内实验
    Animal Model:SNU-16 xenografted in BALB/c-nu mice.Dosage:20 mg/kg/day Administration:oral administration (p.o.) 15 days Result:Achieved 63.1% tumor growth inhibition innocuously. Inhibited FGFR phosphorylation and total FGFR2 protein and decreased phosphorylation levels of downstream pPLCγ and ERK1/2.
  • 同义词
    ——
  • 通路
    Others
  • 靶点
    Other Targets
  • 受体
    PROTACs | FGFR
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    2828438-38-4
  • 分子量
    899.78
  • 分子式
    C43H44Cl2N10O8
  • 纯度
    >98% (HPLC)
  • 溶解度
    In Vitro:?DMSO 中的溶解度 : 130 mg/mL (144.48 mM; 超声助溶 (<60°C)
  • SMILES
    O=C(NC=1C(Cl)=C(OC)C=C(OC)C1Cl)N(C=2N=CN=C(C2)NC3=CC=C(C=C3)N4CCN(C(=O)C5CCN(C6=CC=C7C(=O)N(C(=O)C7=C6)C8C(=O)NC(=O)CC8)CC5)CC4)C
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Ma L, et al. Discovery of a Selective and Orally Bioavailable FGFR2 Degrader for Treating Gastric Cancer. J Med Chem. 2023 Jun 8;66(11):7438-7453.?
产品手册
关联产品
  • 1,2-Dodecanediol

    1,2-Dodecanediol (dodecane-1,2-diol) can be used to synthesize disulfonic acid polymers.

  • C75

    C75 是合成脂肪酸合酶 (FASN) 的抑制剂,可抑制前列腺癌细胞 PC3 (IC50: 35 μM)。

  • Dehydrotumulosic aci...

    脱氢肿瘤酸具有抗炎活性。